Multiple AMPK activators, such as A769662 [35] and the widely used diabetes medication metformin [36, 37], have been reported to inhibit hepatic lipogenesis, suppress glucose production, and improve insulin sensitivity. This evidence concerns the gene INS and diabetes mellitus.